RETRACTED ARTICLE: Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin
Open Access
- 17 June 2013
- journal article
- retracted article
- Published by Springer Nature in Oncogene
- Vol. 33 (19) , 2441-2453
Abstract
Integrin expression and activity are altered in tumors, and aberrant integrin signaling promotes malignancy. However, how integrins become altered in tumors remains poorly understood. We discovered that oncogenic activation of MEK signaling induces cell growth and survival, and promotes the malignant phenotype of mammary epithelial cells (MECs) by increasing α5 integrin expression. We determined that MEK activates c-Myc to reduce the transcription of the SWI/SNF chromatin remodeling enzyme Brahma (BRM). Our studies revealed that reduced BRM expression and/or activity drives the malignant behavior of MECs by epigenetically promoting C/EBPβ expression to directly induce α5 integrin transcription. Consistently, we could show that restoring BRM levels normalized the malignant behavior of transformed MECs in culture and in vivo by preventing C/EBPβ-dependent α5 integrin transcription. Our findings identify a novel mechanism whereby oncogenic signaling promotes malignant transformation by regulating transcription of a key chromatin remodeling molecule that regulates integrin-dependent stromal–epithelial interactions.Keywords
This publication has 58 references indexed in Scilit:
- SWI/SNF nucleosome remodellers and cancerNature Reviews Cancer, 2011
- Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer riskOncogene, 2011
- Transcriptional Repression: The Dark Side of MycGenes & Cancer, 2010
- Regulation of β4-integrin expression by epigenetic modifications in the mammary gland and during the epithelial-to-mesenchymal transitionJournal of Cell Science, 2009
- Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signalingJournal of Clinical Investigation, 2009
- Mammary Epithelial-Specific Disruption of Focal Adhesion Kinase Retards Tumor Formation and Metastasis in a Transgenic Mouse Model of Human Breast CancerThe American Journal of Pathology, 2008
- Tumor cell invasiveness correlates with changes in integrin expression and localizationOncogene, 2005
- Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.2003
- The α2 and α5 integrin genes: identification of transcription factors that regulate promoter activity in epidermal keratinocytesFEBS Letters, 2000
- Overexpression of C/EBP -LIP, a Naturally Occurring, Dominant-Negative Transcription Factor, in Human Breast CancerJNCI: Journal of the National Cancer Institute, 1997